Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, March 23, 2013 - 9:59am
tags:
Corcept Therapeutics, Vivus, Cempra
Why Anacor Cannot Be Contained (video)
Motley Fool
Saturday, March 23, 2013 - 9:53am
tags:
Anacor
Gilead Keeps on Building (video)
Motley Fool
Saturday, March 23, 2013 - 9:53am
tags:
Gilead Sciences
Rockwell Poised For Post-Offering Bounce Ahead Of Phase III Results
Seeking Alpha
Saturday, March 23, 2013 - 9:52am
tags:
Rockwell Medical, Soluble Ferric Pyrophosphate, renal disease
Will This Treatment Help Anacor’s Stock Soar?
Wall Street Cheat Street
Saturday, March 23, 2013 - 9:50am
tags:
Anacor, AN2728, eczema
Reasons To Consider Eli Lilly Over Other Pharmaceutical Giants
Seeking Alpha
Saturday, March 23, 2013 - 9:49am
tags:
Eli Lilly
U.K. Regulators Sour on Novartis Breast Cancer Drug Afinitor
Motley Fool
Saturday, March 23, 2013 - 9:48am
tags:
Novartis, Afinitor, breast cancer
Circassia to Sell Own Cat-Allergy Vaccine If Test Works
Bloomberg
Saturday, March 23, 2013 - 9:47am
tags:
Circassia, vaccines, allergies
AstraZeneca/Moderna Ink Deal
Yahoo/Zacks
Saturday, March 23, 2013 - 9:45am
tags:
AstraZeneca, Moderna
Europe and US Diverge On Two New Drugs
Forbes
Saturday, March 23, 2013 - 9:41am
tags:
Xarelto, mipomersen, JNJ, Genzyme
Why Titan Pharmaceuticals Is Currently Undervalued
Seeking Alpha
Saturday, March 23, 2013 - 9:03am
tags:
Titan Pharmaceuticals
6 Reasons To Buy Arena Pharmaceuticals Right Now
Seeking Alpha
Saturday, March 23, 2013 - 9:03am
tags:
Arena Pharmaceutical
Law Office of Brodsky & Smith, LLC Announces Investigation of Obagi Medical Products, Inc.
Yahoo/PR Newswire
Saturday, March 23, 2013 - 9:01am
tags:
Obagi Medical Products, lawsuits
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
Seeking Alpha
Saturday, March 23, 2013 - 9:00am
tags:
Delcath, Aveo Pharmaceutical, tivozanib, renal cell carcinoma, Chemosat, melanoma, metastatic melanoma
Why Celgene's Management Is a Strength
Motley Fool
Saturday, March 23, 2013 - 8:58am
tags:
Celgene
GenVec Q4 Net Loss Deepens
Motley Fool
Saturday, March 23, 2013 - 8:56am
tags:
GenVec, earnings
Ariad's Potential Blockbuster Set for EU Debut
Motley Fool
Saturday, March 23, 2013 - 8:54am
tags:
Ariad, Iclusig, chronic myeloid leukemia
Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board
Yahoo/GlobeNewsWire
Saturday, March 23, 2013 - 8:52am
tags:
Gilead Pharmasset, Idenix, hepatitis C, patents
Titan Shares Rise After FDA Panel Backs Opioid Implant
Bloomberg
Saturday, March 23, 2013 - 8:49am
tags:
Titan Pharmaceuticals, Probuphine, opioid addiction
Biogen, Baxter, Sanofi, Gilead Win EU Endorsements
Investors.com
Friday, March 22, 2013 - 11:45am
tags:
Biogen Idec, Baxter International, Sanofi, Gilead, Europe, BG-12, Tecfidera, Aubagio, HyQvia, Halozyme, Stribild

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.